Xiaowu L. Zhong

Nanchong, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Integrated analysis of Morusin inhibiting esophageal cancer via network pharmacology molecular dynamics simulation and in vitro validation.

Integrated analysis of Morusin inhibiting esophageal cancer via network pharmacology molecular dynamics simulation and in vitro validation.

Journal: Discover oncology

Published: November 24, 2025

Driver gene mutations and clinical features predict bone metastasis risk in NSCLC: a logistic regression model.

Driver gene mutations and clinical features predict bone metastasis risk in NSCLC: a logistic regression model.

Journal: Cancer genetics

Published: November 04, 2025

Fedratinib reveals chemotherapeutic potential in esophageal squamous cell cancer.

Fedratinib reveals chemotherapeutic potential in esophageal squamous cell cancer.

Journal: Frontiers in pharmacology

Published: August 20, 2025

Elbasvir triggers ferroptosis in esophageal squamous cell carcinoma through NCOA4-mediated ferritinophagy.

Elbasvir triggers ferroptosis in esophageal squamous cell carcinoma through NCOA4-mediated ferritinophagy.

Journal: Medical oncology (Northwood, London, England)

Published: July 31, 2025

Differentiating bacterial from viral respiratory tract infections using CRP, SAA, and blood routine parameters: A retrospective cohort study.

Differentiating bacterial from viral respiratory tract infections using CRP, SAA, and blood routine parameters: A retrospective cohort study.

Journal: Clinics (Sao Paulo, Brazil)

Published: April 30, 2025

A catalytic hairpin assembly system with sliding replication for the detection of piRNAs.

A catalytic hairpin assembly system with sliding replication for the detection of piRNAs.

Journal: The Analyst

Published: April 01, 2025

Recent advances in biomarker detection of oral squamous cell carcinoma.

Recent advances in biomarker detection of oral squamous cell carcinoma.

Journal: Frontiers in oncology

Published: March 20, 2025

Targeting Telomere Shelterin Protein TPP1 with Elbasvir: Induction of Autophagy and Suppression of Esophageal Cancer Tumorigenesis.

Targeting Telomere Shelterin Protein TPP1 with Elbasvir: Induction of Autophagy and Suppression of Esophageal Cancer Tumorigenesis.

Journal: Anti-cancer agents in medicinal chemistry

Published: March 16, 2025

STM2457 impairs the proliferation of esophageal squamous cell carcinoma by activating DNA damage response through ATM-Chk2 axis.

STM2457 impairs the proliferation of esophageal squamous cell carcinoma by activating DNA damage response through ATM-Chk2 axis.

Journal: Medical oncology (Northwood, London, England)

Published: December 10, 2024

Exploring the novel role and mechanistic insights of skeletal muscle relaxant cyclobenzaprine hydrochloride in esophageal squamous cell carcinoma treatment.

Exploring the novel role and mechanistic insights of skeletal muscle relaxant cyclobenzaprine hydrochloride in esophageal squamous cell carcinoma treatment.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: November 25, 2024

YY2 Serves as a Novel Prognostic Biomarker Correlated with Immune Microenvironment and Glycolysis in Esophageal Carcinoma.

YY2 Serves as a Novel Prognostic Biomarker Correlated with Immune Microenvironment and Glycolysis in Esophageal Carcinoma.

Journal: Current genomics

Published: October 08, 2024

Controlling the Crystal Growth of DNA Molecules via Strategic Chemical Modifications.

Controlling the Crystal Growth of DNA Molecules via Strategic Chemical Modifications.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: January 03, 2024

Showing 1-12 of 39

Last Updated: 09/26/2026